Nanoformulation d'une molécule antirétrovirale pour le ciblage des réservoirs du VIH-1
Bien que les multithérapies aient révolutionné le traitement de l'infection VIH, ces traitements échouent aujourd'hui encore à éradiquer le virus de l'organisme. En cause, la faible accessibilité des antirétroviraux à certains tissus, notamment lymphoïdes, empêche l'élimination...
Main Author: | Quaillet, Marion |
---|---|
Other Authors: | Université Paris-Saclay (ComUE) |
Language: | fr |
Published: |
2018
|
Subjects: | |
Online Access: | http://www.theses.fr/2018SACLS472 |
Similar Items
-
Enfuvirtida para o tratamento do paciente com aids: o divisor de águas Enfuvirtide in the treatment of AIDS patient: the turning point
by: Daniele Viana Maia Torres, et al.
Published: (2010-06-01) -
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype
by: Cunyat Francesc, et al.
Published: (2012-02-01) -
Effect of Amphipathic HIV Fusion Inhibitor Peptides on POPC and POPC/Cholesterol Membrane Properties: A Molecular Simulation Study
by: Luís M. S. Loura, et al.
Published: (2013-07-01) -
Resistência natural ao T-20 em gestantes infectadas pelo HIV-1 do estado de Goiás
by: Reis, Mônica Nogueira da Guarda
Published: (2014) -
Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide
by: Adam S. Dingens, et al.
Published: (2019-05-01)